148 related articles for article (PubMed ID: 25622345)
81. Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapy.
Scialla SJ; Miskoff RA
JAMA; 1976 May; 235(22):2416-7. PubMed ID: 946650
[No Abstract] [Full Text] [Related]
82. Topical tretinoin treatment in basal cell carcinoma.
Brenner S; Wolf R; Dascalu DI
J Dermatol Surg Oncol; 1993 Mar; 19(3):264-6. PubMed ID: 8445111
[TBL] [Abstract][Full Text] [Related]
83. Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil.
Midena E; Boccato P; Angeli CD
Arch Ophthalmol; 1997 Dec; 115(12):1600-1. PubMed ID: 9400803
[No Abstract] [Full Text] [Related]
84. Transdermal delivery of 5-fluorouracil for induced ehrlich ascites carcinoma tumor in BALB/c mice and pharmacokinetic study.
Chandrashekar NS; Hiremath SR
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):235-9. PubMed ID: 18221066
[TBL] [Abstract][Full Text] [Related]
85. Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
Gracia-Cazaña T; González S; Gilaberte Y
Actas Dermosifiliogr; 2016 Nov; 107(9):730-739. PubMed ID: 27436800
[TBL] [Abstract][Full Text] [Related]
86. [Histochemical studies of basal cell epithelioma treated with 5-fluorouracil ointment].
Chodynicka B
Przegl Dermatol; 1975; 62(1):95-102. PubMed ID: 163028
[No Abstract] [Full Text] [Related]
87. Intradermal 5-fluorouracil in the treatment of basal cell carcinoma of the face.
Avant WH; Huff RC
South Med J; 1976 May; 69(5):561-3. PubMed ID: 1273611
[TBL] [Abstract][Full Text] [Related]
88. Intralesional 5-Fluorouracil for the Nonsurgical Management of Low-Risk, Invasive Squamous Cell Carcinoma.
Dando EE; Lim GFS; Lim SJM; Kim C; Pugliano-Mauro M
Dermatol Surg; 2020 Jan; 46(1):126-130. PubMed ID: 30608299
[No Abstract] [Full Text] [Related]
89. Rate and Proportion of Malignant Skin Biopsies for Basal Cell and Squamous Cell Carcinoma on the Face and Ears After a Single Course of Topical 5-Fluorouracil: The Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
Means AD; Leader NF; Siegel JA; Arron ST; Walker JL; Pomerantz H; Beatson M; Weinstock MA
Dermatol Surg; 2021 Apr; 47(4):541-543. PubMed ID: 33795573
[No Abstract] [Full Text] [Related]
90. A clinical trial of the use of 5-fluouracil in the treatment of some cutaneous malignancies.
Littlewood M; Murray DS
Br J Plast Surg; 1973 Apr; 26(2):140-6. PubMed ID: 4574777
[No Abstract] [Full Text] [Related]
91. Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution.
Diluvio L; Lanna C; Lozzi F; Palumbo V; Bianchi L; Campione E
Dermatol Ther; 2019 May; 32(3):e12908. PubMed ID: 30968527
[TBL] [Abstract][Full Text] [Related]
92. Basal-cell carcinoma of large dimension.
Klostermann GF
Dermatologica; 1970; 140():Suppl 1:54. PubMed ID: 5471362
[No Abstract] [Full Text] [Related]
93. Fluorouracil and other predictors of morpheaform basal cell carcinoma among high-risk patients: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Xiong MY; Korgavkar K; Digiovanna JJ; Weinstock MA;
JAMA Dermatol; 2014 Mar; 150(3):332-4. PubMed ID: 24258386
[No Abstract] [Full Text] [Related]
94. Chemotherapy of skin cancer.
Klein E; Case RW; Burgess GH
CA Cancer J Clin; 1973; 23(4):228-31. PubMed ID: 4200101
[No Abstract] [Full Text] [Related]
95. Topical 5-fluorouracil in treatment of carcinoma of nasal floor and nasal alae.
Ryan RF; Marks MW
Ann Plast Surg; 1988 Jan; 20(1):48-54. PubMed ID: 3341716
[TBL] [Abstract][Full Text] [Related]
96. Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma.
Peris K; Ferrari A; Fargnoli MC; Piccolo D; Chimenti S
Dermatol Surg; 2005 Feb; 31(2):217-20. PubMed ID: 15762218
[No Abstract] [Full Text] [Related]
97. Intralesional 5-fluorouracil for the treatment of squamous cell carcinomas.
Maxfield L; Shah M; Schwartz C; Tanner LS; Appel J
J Am Acad Dermatol; 2021 Jun; 84(6):1696-1697. PubMed ID: 33378661
[No Abstract] [Full Text] [Related]
98. Treatment of basal cell carcinoma with 5-fluorouracil (5-FU) ointment.
Reymann F
Dermatologica; 1970; 140():Suppl 1:34-41. PubMed ID: 4919323
[No Abstract] [Full Text] [Related]
99. Treatment of basal cell carcinoma with intralesional interferon.
Greenway HT; Cornell RC; Tanner DJ; Peets E; Bordin GM; Nagi C
J Am Acad Dermatol; 1986 Sep; 15(3):437-43. PubMed ID: 3760271
[TBL] [Abstract][Full Text] [Related]
100. [Current Management of Basal Cell Carcinoma].
Krieter M; Schultz E
Dtsch Med Wochenschr; 2023 Sep; 148(17):1081-1087. PubMed ID: 37611571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
